key: cord-0831493-cx3sqqa2 authors: Ginex, Tiziana; Marco-Marín, Clara; Wieczór, Miłosz; Mata, Carlos P.; Krieger, James; López-Redondo, Maria Luisa; Francés-Gómez, Clara; Ruiz-Rodriguez, Paula; Melero, Roberto; Sánchez-Sorzano, Carlos Óscar; Martínez, Marta; Gougeard, Nadine; Forcada-Nadal, Alicia; Zamora-Caballero, Sara; Gozalbo-Rovira, Roberto; Sanz-Frasquet, Carla; Bravo, Jeronimo; Rubio, Vicente; Marina, Alberto; Geller, Ron; Comas, Iñaki; Gil, Carmen; Coscolla, Mireia; Orozco, Modesto; Llácer, José Luis; Carazo, José-Maria title: The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: the case of the spike A222V mutation date: 2022-02-22 journal: bioRxiv DOI: 10.1101/2021.12.05.471263 sha: c04756898c9b9fddfcaa2a71b63419fe31046d04 doc_id: 831493 cord_uid: cx3sqqa2 The S:A222V point mutation, within the G clade, was characteristic of the 20E (EU1) SARS-CoV-2 variant identified in Spain in early summer 2020. This mutation has now reappeared in the Delta subvariant AY.4.2, raising questions about its specific effect on viral infection. We report combined serological, functional, structural and computational studies characterizing the impact of this mutation. Our results reveal that S:A222V promotes an increased RBD opening and slightly increases ACE2 binding as compared to the parent S:D614G clade. Finally, S:A222V does not reduce sera neutralization capacity, suggesting it does not affect vaccine effectiveness. The repeated emergence of the same mutations across time and lineages suggests the action of positive selection and a functional role for the less-characterized mutations. Nevertheless, the reasons underlying the genetic success of these mutations and the role of the genetic background remains to be defined. A spike mutation common to almost all the strains circulating today is S:D614G. This mutation appeared early in the pandemic and has been associated with higher fitness in experimental work in vitro, in vivo and in epidemiological settings (Korber et al. 2020; Plante et al. 2021; Yang et al. 2021) . In particular, S:D614G has been reported to affect the conformational landscape of the spike glycoprotein (Yurkovetskiy et al. 2020; Benton et al. 2021; Gobeil et al. 2021) , so that a particular domain known as the Receptor Binding Domain (RBD), discussed further in this work, may be more exposed for increased interactions with the main cellular receptor ACE2 (Ozono et al. 2021) . As a consequence, S:D614G variants outcompeted the initial 614D Wuhan-Hu-1 variant across the globe, although the S:D614G mutation alone cannot explain the success of the associated variants and probably there was a combined effect with a founder event (van Dorp et al. 2020 ). Likewise, a new variant emerged during the summer of 2020, 20E/EU1, which was characterized by the additional spike mutation, S:A222V. This mutation has been seen both before and after summer 2020 in other genetic backgrounds, including Delta (as indicated in the Results section), suggesting that the mutation had a functional effect and may explain the success of the associated variant. However, in-depth analysis of the population dynamics of the variant in different countries suggested that the success of 20E/EU1 was a by-product of lifting restrictions in Europe after the first lockdown and holidayassociated travels across Europe (Hodcroft et al. 2021) . This opens the question of why S:A222V has been selected multiple times in the evolution of SARS-CoV-2 and what the functional role of the mutation in viral replication or transmission is. Here, we use S:A222V as an example of those mutations that have arisen multiple times in the SARS-CoV-2 spike protein in different genetic backgrounds but had no associated increased epidemiological fitness. Tracing the interactions with the genetic background in which they appear (epistasis) could help in predicting the potential success of these new mutations in the population. To clarify the role of S:A222V, we have used an extensive genomic dataset describing their population dynamics across SARS-CoV-2 lineages. We have also studied the role of the genetic background by combining the mutation S:A222V with S:D614G in neutralization experiments with pseudotyped viruses, followed by biophysical characterization of the mutant spike. On the structural side, we report here the cryo Electron Microscopy (cryo-EM) map and structural model of the 1-up conformation of 20E/EU1 (7QDG, EMD-13916) and the ubiquitous S:D614G mutant (7QDH, EMD-13919). Cryo-EM and Molecular Dynamics (MD) simulations were finally combined to obtain indications about the functional role of the mutation. This multidisciplinary approach allowed us to provide a plausible answer to the repeated emergence of the S:A222V mutations, which could be summarized as an allosteric effect resulting in an enhanced flexibility of the RBD in the up state, although its translation into significant phenotypic effects depends on the genetic background. Finally, serological neutralization studies and in vitro thermostability assays did not show a marked difference between the two strains, suggesting it does not affect vaccine effectiveness. The mutation S:A222V first arose within Lineage B.1.177, described for the first time in Spain in Summer 2020 (Hodcroft et al. 2021) . S:A222V has been observed in 290,789 sequences of 123 countries by September 2021, almost exclusively co-occurring with S:D614G (99.86%). Additionally, 9% of 3,227,996 SARS-CoV-2 sequences available until 2021-10-24 include [S:A222V + S:D614G] and only 0.012% harbour S:A222V without S:D614G, indicating that the presence of S:A222V is tightly linked to S:D614G. Interestingly, although S:A222V arose with B.1.177, by September 2021 more than half of the sequences with S:A222V were not in the genomic context of B.1.177, indicating that although B.1.177 was replaced by other variants (Hodcroft et al. 2021 Figure 1a ) shows two peaks, the first corresponding to the dynamics of 20E (green line in Figure 1a ) and the second to the expansion of B.1.617.2 (VOC Delta) (yellow line in Figure 1a ). We did not observe a similar peak in S:A222V during the increase of B.1.1.7 (VOC Alpha; blue line in Figure 1a ), possibly suggesting that epistatic interactions may favour the transmission of S:A222V preferentially in some genetic backgrounds. To decipher the recent dynamics of S:A222V, we focused on B.1.617.2 in a global dataset of 1,453,295 sequences (Figure 1b and c) . B.1.617.2 sequences with S:A222V belong to different sub-lineages, being characteristic of four sub-lineages: AY.4.2, AY.9, AY.26 and AY.27, where it is present in more than 95% of the sequences of each sub-lineage (Figure 1c) . However, S:A222V is also present in 25% of sequences classified as the parental B.1.617.2 lineage, and in 1.31% of other B.1.617.2 sub-lineages (Figure 1c) . S:A222V has appeared at least 32 times in the genomic context of B.1.617.2, being detected in at least 176 different sub-lineages (Figure 1c) . Conversely, since July 2021, the proportion of B.1.617.2 (and S:A222V along with it) has been increasing mainly due to the increase of AY.4.2 (Figure 1b) . Among the different appearances of S:A222V in the different genomic backgrounds, it has been successfully transmitted on at least two occasions: one in the last common ancestor of AY.4.2 and the other in the common ancestor of Lineages AY.9, AY.26 and AY.27 (Figure 1c) . Additionally, eight other less abundant lineages which derive from the same common ancestor as AY.9, A.26 and AY.27 also have S:A222V ( Figure 1c ). One possibility for the selection of S:A222V could be an improved ability to replicate in immune populations. As vaccination had not yet started in Spain when this mutation was first observed in 2020, any such effect would have to result from selection for escape from existing immunity in convalescent individuals. To test this possibility, we evaluated the ability of VSV pseudotyped with either the ancestral Wuhan-Hu-1 spike protein, S:D614G, or 20E ([S:A222V + S:D614G]) to be neutralized by sera from the first wave of infection in Spain (April 2020) when no S:A222V mutations were circulating (Figure 1) . No significant differences were observed in neutralization between the different viruses (Figure 2) . No significant differences were detected between any of the sera (n=6; p>0.05 by Kruskal-Wallis test; p>0.05 by Mann-Whitney test for Wuhan-Hu-1 vs. S:D614G, Wuhan-Hu-1 vs. 20E, or S:D614G vs. Wuhan-Hu-1). The ectodomain of SARS-CoV-2 protein S corresponding to the Wuhan-Hu-1, S:D614G or [S:A222V + S:D614G] variants, hosting proline substitutions at residues 986 and 987, a mutant non-cleavable sequence at the furin site and a C-terminal foldon trimerization motif, were flashpurified (1 day) identically and used fresh. The three forms were indistinguishable by SDS-PAGE and eluted identically from a SEC column (Supplementary Figure 2a-b) , as expected if they had essentially the same size and glycosylation pattern. Their quality, assessed by negative-stain electron microscopy (EM), was also similarly high (Supplementary Figure 2c) . To functionally characterize the purified protein S variants, we first used thermal shift assays to measure their thermostability and we found that [S:A222V + S:D614G] and S:D614G variants show very similar half-melting temperatures (T0.5) and are both slightly more stable than the original Wuhan-Hu-1 variant ( Table 1 and Supplementary Figure 3) . Then, to see the possible impact of the S:A222V mutation on the spike binding capacity to the protein ACE2, we carried out protein-protein interaction assays by biolayer interferometry (BLI) ( Table 1 ) and that assignment into classes is provided with mean and standard deviation information. The sample, under the conditions indicated in Methods, presented a majority conformation 1-up with about 50% of the particles (after consensus), although two minority but stable 2-up (1.6%) and 3-down (1.9%) conformations were also found through symmetry relaxation (Supplementary (Figures 4b and 5c , and Movie 1). All these movements affect the degree of tightening of the S1 region of the spike (Movie 1), so that the global conformation of the [S:A222V + S:D614G] mutant seems to be tighter than that of S:D614G. This is mainly a consequence of the tightening of subunit B around RBDA. In this direction, the distance between residues 114 and 381 (Figure 4b) Table 2) . We initially analysed these simulations via principal component analysis (PCA) focusing on a single S1 subunit (Methods). The projections on the first two eigenvectors for the MD simulated mutants, collectively capturing 82% of the structural variance within the conformational landscape explored by the S1, are shown in Figure 5a . To characterize the relative impact of glycosylation on the conformational preferences observed for the previously analysed glycan-free systems, we also simulated both mutants from the fully glycosylated structure (Methods). Since no relevant effects, relative to the observed phenomenon, were produced by the S:A222V mutation on the conformational ensemble of the 3-down closed state To account for potential interdomain allosteric implications, we also analysed the effects induced by the RBD opening on the other two closed RBDs within the same trimeric ensemble of the simulated 1-up trajectories (Supplementary Figure 10a , c, and e). For completeness, data obtained from this analysis were also compared with those for the whole S1 units (Supplementary Figure 10b , d, and f). A slightly higher dynamical behaviour was observed at the level of the closed S1/RBD units for the simulated (glycan-free) cryo-EM mutants ( Supplementary Figure 10c and d) , with values spreading between -15 and 5 along the PC1 S1/RBD . A tendency to more negative values for the two The relative values of betweenness centrality, reported in Figure 6c , show a dramatic difference in the extent of connectivity between the two domains which is mainly driven by hydrophobic contacts. In the three datasets, the [S:A222V + S:D614G] mutant forms at most a single strong "pivot" connection between the two domains (see violet community pairs 2 NTD -2 RBD and 3 NTD -4 RBD for UDD and gly-UDD respectively in Figure 6c) , thereby allowing for a degree of flexibility in their relative geometry, while the S:D614G mutant forms 3-6 stable contacts (mainly involving communities 1 and 3 of the NTD with 2 and 4 of the RBD in Figure 6c ). This last network is extensive enough to stabilize the RBD in a single dominant conformation. No stable connections were found between the RBD-NTD pair of the cryo-EM [S:A222V + S:D614G] mutant below the selected contact cut-off of 4.5 Å. As above, this trend shows up consistently across the three different setups -i.e., independent of both glycosylation and the source of the initial structure. Structural flexibility of PDB-reported S:D614G single mutant. In an attempt to provide more details about the dynamics of the S:D614G mutant, especially from a wider timescale perspective, a set of 24 structures of S:D614G previously reported in the PDB were also analysed by PCA together with our new cryo-EM structures. Note that the whole process of sample preparation for cryo-EM may take from seconds to minutes, therefore we expect that the individual images that support these PDB structures came from virtually any possible conformational state of the spike, although the maps themselves are the result of an image processing process which might not be able to accurately follow these structural variations. We also remark that for structures analyzed in this PDB-wide approach, specimens may differ among themselves in more mutations than S:D614G and S:A222V alone, related to different ways to aid purification of stable spike trimers e.g. adding tags, eliminating cleavage sites and introducing proline mutations (Supplementary Table 4) ; still, all these structures were pooled together and analysed using PCA (Figure 7 and Supplementary Figures 11 and 12 ). The much smaller size of the ensemble as compared to that from MD simulations allowed us to analyse the dynamics of the whole spike, which produced very similar motions of the dominant subunit to those seen when focusing on the first S1 subunit involved in RBD opening as above, especially in the first three eigenvectors (Supplementary Figure 11a- Figure 12d-e) . PC1 showed coupled opening and closing of these two RBDs ( Figure 7d) ; whereas PC2 showed one opening while the other closed (Figure 7e ). There was a dominance of the first RBD in PC1 (Supplementary Figure 12d) and a dominance of the second RBD in PC2 (Supplementary Figure 12e) , enabling a much clearer separation of 2-up structures in the projection onto these two PCs (Figure 7f) . We again see that our two cryo-EM structures reside in the middle of the 1-up cluster, showing room for further opening of both dominant RBDs within the 1-up macrostate. We In conclusion, the S:A222V mutation at the NTD of the SARS-CoV-2 spike sequence is able to produce small but noticeable allosteric effects in the RBD that translate into changes in its conformational dynamics as well as biophysical properties. These findings agree with the recall of the S:A222V across waves, lineages, and space, suggesting a role for positive selection. Still, the genetic background in which the mutation occurs seems to be crucial for its The global dataset of 3,227,996 sequences was obtained from GISAID database (Elbe and The plasmids used for the generation of the pseudotype vesicular stomatitis virus (VSV) were previously described (Ruiz-Rodriguez et al. 2021) . Plasmid pSPIKE (a generous gift from Cesar Santiago, CNB-CSIC) was designed to include the region encoding the SARS-CoV-2 protein S ectodomain (residues 15-1213) with substitutions to proline at residues 986 and 987 and of 668 RRAR 671 furin cleavage site to alanine, with a N-terminal gp67 signal peptide for secretion, and C-terminal foldon trimerization motif, a thrombin protease recognition site and 9x His and Myc tags, into the insect expression plasmid pFastBac. Plasmid pACE2TEV was prepared from that previously used to express the N-terminal peptidase domain of human ACE2 (Lan et al. 2020 ), by including a cleavage site for TEV protease, to allow removing the C-terminal 6×His tag in an additional purification step. Pseudotyped VSVDG-GFP bearing the ancestral Wuhan-Hu-1, the S:D614G, or 20E (mutations S:A222V and S:D614G) spike protein were produced as previously described (Ruiz-Rodriguez et al. 2021) . Neutralization assays were performed as previously described (Ruiz-Rodriguez et al. 2021 ). Briefly, 16 h post infection GFP signal derived from VSV replication was determined in each well using an Incucyte S3 system (Essen Biosciences). The mean GFP signal observed in several mock-infected wells was subtracted from that of all infected wells, followed by standardization of the GFP signal in each well infected with antibody-treated virus to that of wells infected with mock-treated virus. Any low or negative values resulting from background subtraction were arbitrarily assigned a low, nonzero value (0.001). The serum dilutions were then converted to their reciprocal and the dose resulting in a 50% reduction in GFP signal was calculated using the R drc package v 3.0-1. A three-parameter log-logistic regression (LL3 function) was used for all samples. All serum samples were from donors that were admitted to the intensive care unit during April 2020 (ethics approval RVB20017COVID). Site-directed mutagenesis of pSpike was performed using Q5® Site-Directed Mutagenesis Kit (New England Biolabs) and the forward and reverse primers given in Supplementary Table 5 GL column (Cytiva) pre-equilibrated with 10 mM sodium-Hepes pH 7.2, 150 mM NaCl (SEC buffer), also collecting 0.2-ml fractions, of which those containing SARS-CoV-2 S protein were aliquoted, flash-frozen in liquid nitrogen and stored at -80 ºC. SARS-coV-2 S protein concentration was determined spectrophotometrically from the optical absorption at 280 nm, using a sequencededuced (EXPASY ProtParam tool, https://www.expasy.org) mass extinction coefficient (E 1%) of 10.29 g -1 L cm -1 . ACE2 was produced and purified essentially as described for SARS-CoV-2 protein S, except for the fact that before SEC, the polyhistidine tag was removed by digestion with TEV protease (37.5 µg per each mg of ACE2, overnight, 4ºC) within a dialysis bag dialyzed against SEC buffer supplemented with 5 mM EDTA and 0.5 mM mercaptoethanol. Nontagged ACE2 was isolated by an additional Ni-affinity chromatography step, using a 1 mL-HisTrap TM Excel column (Cytiva). In this step, the untagged protein was collected in the initial fraction not retained by the column (application and 2-mL wash). After concentration by centrifugal ultrafiltration (30-kDa cutoff membrane), the protein was further purified by SEC as described for SARS-CoV-2 protein S, quantifying ACE2 by its optical absorption at 280 nm (mass extinction coefficient, 21.9 g -1 L cm -1 was considered as mass extinction coefficient (E1%). The absence of the polyhistidine tag in the purified protein was verified by western blot using antihistidine antibodies. Thermal shift assays. Thermofluor assays (Vedadi et al. 2006) Plots, curve fittings and numerical calculations were performed with the program GraphPad Prism 5 (GraphPad Software, San Diego, CA, USA). Results given in Table 1 correspond to the mean and standard error for six replicate assays carried in groups of three replicates in two independent experiments. Biolayer Interferometry assays. Binding assays of ACE2 to His-tagged S proteins were performed in the Octet K2 instrument (ForteBio). The assays were carried out at 28ºC, shaking was kept at 1,000 rpm and the solution was 20 mM Hepes, 150 mM NaCl, 50 μM EDTA, 10 mM imidazole and 0.005% Tween 20 (buffer AB). His-tagged Spike proteins at 0.1 μg/ml in solution AB were immobilized (240 s) on Ni-NTA biosensors hydrated in the same buffer, yielding a typical signal of ~2 nm. After another 240 sec equilibration of the biosensors with buffer AB to get a stable baseline, binding was assayed by adding serial 1:2 dilutions of ACE2 in the range 250-3.9 nM. Both the association and the dissociation phases lasted 120 s each. Negative drift controls were carried out without ACE2 and a 1:1 binding model was used for data fitting. criterion. Several datasets were also selected for applying the C3 symmetry approach, being refined to resolutions of 3.2 Å and 3.7 Å. The dataset with the highest number of particles was then 3D classified in Relion3.1 (Scheres 2012) using the symmetry relaxation protocol (Ilca et al. 2019; Goetschius et al. 2019) , which relaxes the dominant symmetry by considering multimodal priors centered at the symmetry related positions. A 30 Å low-pass filtered reconstruction with no symmetry resulting from a randomly selected subset of 10,000 symmetry broken particles (Goetschius et al. 2019 ) was used as the initial model for the 3D classification. This protocol was repeated three times with the same parameters and to overcome the variability in the results, the Scipion 3D classification consensus protocol was used to better characterize the different conformations ). An initial model was generated for each class/conformation and subsequently refined to a resolution of 3 Standard protonation states at pH 7.4 were adopted for ionizable residues. The same N-and Oglycosylation profile, consisting of 22 N-glycans and 1 O-glycan per each monomer as described in the work of Woo H. et al. 2020 (Woo H. et al. 2020) , was applied for the simulation. Finally, for all the simulated systems, the protein was enclosed in a truncated octahedron box, solvated with TIP3P (Jorgensen et al. 1983 ) water molecules and neutralized by adding Na + or K + /Clcounterions (Joung and Cheatham 2008) . A detailed description of all the MD systems studied in this work is reported in Supplementary Table 2. MD simulations. Classical MD simulations were carried out with Gromacs v. 2020 (Abraham et al. 2015) . The systems were energy minimized by applying 50,000 steps of the steepest descent algorithm followed by 5,000 steps of conjugate gradient algorithm. 1 ns of MD simulation in the NVT ensemble (Bussi et al. 2007 ) was run using the velocity-rescaling thermostat and a time coupling constant of 0.1 ps to heat the systems to the production temperature of 300 K. Positional restraints with a force constant of 1,000 kJ mol −1 mn −2 were applied to the protein backbone atoms to avoid unnatural distortions during heating. Equilibration to the target temperature was then accomplished in two steps consisting of (i) 5 ns of unrestrained equilibration in the NPT ensemble using Berendsen thermostat (0.1 ps time coupling constant) and barostat (0.5 ps time coupling constant) and (ii) 5 ns of unrestrained MD simulation in the NPT ensemble by using Berendsen thermostat (0.1 ps time coupling constant) and Parrinello-Rahman barostat (0.5 ps time coupling constant) (Parrinello 1981 Table 2 ). In all the cases, the LINCS method (Hess et al. 1998 ) was applied to constraint bonds involving hydrogen atoms. A cut-off of 1.2 nm was used to treat short-range nonbonded interactions, whereas the PME method was applied to manage long-range electrostatic interactions (Darden et al. 1993) . A time step of 2 fs was applied to collect trajectories during the simulation. Convergence assessment. Root-mean-square deviation ( consistency, MD trajectories collected from cryo-EM and glycosylated mutants were also aligned on the previously cited ensemble. Another PCA focused on residues pertaining to the three RBD (residues 330A-530A, 330B-530B, 330C-530C) was also performed and used to calculate continuous density distributions along the first eigenvector (PC1 RBD ). Results from this analysis were compared with those obtained for projection along the first eigenvector (PC1 S1 ) for the whole S1 (residues 30A-650A, 30B-650B, 30C-650C). Dynamic network analysis. The dynamic network analysis was performed using an implementation by Melo et al. (Melo et al. 2020) , following a standard set of parameters, i.e. a contact cut-off of 4.5 Å and contact persistence of 0.5. Since each system consisted of the same selection (open RBD + the neighboring NTD), the reported values of betweenness centrality are absolute rather than normalized within a system. ParmEd (Shirts et al. 2017 ) was used to convert between trajectory and topology formats as required for the analysis. Mutational free energy analysis. Free energy calculations were performed using the nonequilibrium alchemical protocol based on the Crooks theorem (Crooks 1998 ) . The PMX library was used to introduce the modifications (Gapsys et al. 2015) , and an in-house script (gitlab.com/KomBioMol/crooks) was used to run and analyse the free energy calculations. Bennett acceptance ratio (BAR) was used to determine the free energy values (Bennett 1976; Shirts et al. 2003) . Starting points for individual non-equilibrium runs were sampled from 200-ns equilibrium simulations of the respective Spike mutant in the 1-up conformation (prepared as described above), and calculations were repeated for each of the three chains to compare the effect of mutations on the thermodynamic preference for the open, 1-up state. 24 structures from six recent structural studies of the S:D614G spike were analysed together with our two new cryo-EM structures (Supplementary Table 4 ). More structural models were available in the PDB but were not included as they came from earlier rounds of classification as structures that were included (PDB: 7KDK and 7KDL) (Gobeil et al. 2021) or had a poorly resolved S1 subunit (PDB: 6XS6) (Yurkovetskiy et al. 2020) . Principal component analysis was performed using the latest version of the Protein Dynamics (ProDy) application programming interface (API) ) from GitHub as follows. Only Cα atoms were included for efficiency. A structural ensemble was created using a WT 1-up structure (PDB: 6VSB) as a reference for initial alignment, where the chains were relabelled to match our cryo-EM structures. Residues were matched with the default method and chains with a custom matching function using the chain order correspondences in the second last column of Supplementary Table 4 , based on a visual analysis in PyMOL. Initial alignment and superposition to the reference was then followed by iterative superposition until the mean structure converged. According to the protocol used for the PCA of our MD simulations, structures were then iteratively superposed again using only the Cα atoms of core helices of the S2 trimer. The ensemble was then trimmed to exclude residues only found in some structures. Positional covariance matrices were calculated based on the single subunit related to RBD opening as done for the MD simulations as well as the whole spike. In the case of the whole spike, covariance matrices were calculated using both the whole ensemble and a subset lacking the three 2-up structures. The three resulting covariance matrices were each decomposed to yield the first 20 eigenvectors describing the most significant modes of structural variation with eigenvalues corresponding to the extent of variance covered. One to three modes, which contributed >90 % of the variance, were considered the principal components (PCs). Square fluctuations were calculated from all modes as eigenvalue-weighted dot products of corresponding eigenvectors. Matrices of directional overlaps were calculated as correlation cosines. For comparison with the single subunit PCA, after slicing the eigenvectors from the whole spike were sliced to only include elements corresponding to the single subunit. Conformations along individual eigenvectors were generated using the Normal Mode Wizard (NMWiz) (Bakan and Bahar 2011) in VMD (Humphrey et al. 1996) and 40 conformers with an RMSD up to 4 Å in both directions were used for making figures. All the analyzed 3,227,996 SARS-CoV-2 genomes (collected from May 2020 to October 2021) were retrieved from the GISAID platform (https://www.gisaid.org). The Aligned MD trajectories for all the glycan-free and glycosylated S:D614G and [S:A222V + S:D614G] mutants simulated in this study are available at: bioexcel-cv19dev.bsc.es/#/browse?search=Spike%20mutation%20A222V Banco Santander (Proposal: BlockAce), and CSIC PTI Salud Global (Proposal: 202080E110). VR is funded by the Spanish Ministry of Science and Innovation through Grant PID2020-120322RB-C21. IC is funded by project PID2019-104477RB-100, Fondo COVID COV20/00140 and ERC CoG 101001038. MC is funded by the RyC program from the Spanish Ministry of Science and Innovation, the Generalitat Valenciana (SEJI/2019/011). work and helped to build the structural models Consortia The IBV-Covid19-Pipeline: Laura Villamayor (orcid.org/0000-0002-7654-3306) Centro Nacional de Biotecnología GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers A Community Letter Regarding Sharing Biomolecular Simulation Data for COVID-19 Computational generation inhibitor-bound conformers of p38 MAP kinase and comparison with experiments Efficient estimation of free energy differences from Monte Carlo data The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2 Tools for macromolecular model building and refinement into electron cryo-microscopy reconstructions Canonical sampling through velocity rescaling Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein Deep learning-based mixed-dimensional Gaussian mixture model for characterizing variability in cryo-EM Nonequilibrium Measurements of Free Energy Differences for Microscopically Reversible Markovian Systems Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems Scipion: A software framework toward integration, reproducibility and validation in 3D electron microscopy Data, disease and diplomacy: GISAID's innovative contribution to global health Features and development of Coot pmx: Automated protein structure and topology generation for alchemical perturbations D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction CryoEM reconstruction approaches to resolve asymmetric features LINCS: A Linear Constraint Solver for molecular simulations Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 Comparison of multiple Amber force fields and development of improved protein backbone parameters Structure-based design of prefusion-stabilized SARS-CoV-2 spikes VMD: visual molecular dynamics Multiple liquid crystalline geometries of highly compacted nucleic acid in a dsRNA virus Comparison of simple potential functions for simulating liquid water Determination of alkali and halide monovalent ion parameters for use in explicitly solvated biomolecular simulations Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor Improved side-chain torsion potentials for the Amber ff99SB protein force field Energy Landscape of the SARS-CoV-2 Reveals Extensive Conformational Heterogeneity Continuous flexibility analysis of SARS-CoV-2 spike prefusion structures Generalized correlation-based dynamical network analysis: a new high-performance approach for identifying allosteric communications in molecular dynamics trajectories SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity SNP-sites: rapid efficient extraction of SNPs from multi-FASTA alignments SARS-CoV-2 spike opening dynamics and energetics reveal the individual roles of glycans and their collective impact Polymorphic transitions in single crystals: A new molecular dynamics method UCSF Chimera--a visualization system for exploratory research and analysis Spike mutation D614G alters SARS-CoV-2 fitness 3D variability analysis: Resolving continuous flexibility and discrete heterogeneity from single particle cryo-EM 3D flexible refinement: Structure and motion of flexible proteins from cryo-EM cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination S494 Oglycosylation site on the SARS-CoV-2 RBD affects the virus affinity to ACE2 and its infectivity; a molecular dynamics study FSC-Q: a CryoEM map-to-atomic model quality validation based on the local Fourier shell correlation CTFFIND4: Fast and accurate defocus estimation from electron micrographs Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2 DeepEMhancer: a deep learning solution for cryo-EM volume post-processing A Bayesian view on cryo-EM structure determination Geometric machine learning informed by ground truth: Recovery of conformational continuum from singleparticle cryo-EM data of biomolecules SeqKit: A Cross-Platform and Ultrafast Toolkit for FASTA/Q File Manipulation Equilibrium free energies from nonequilibrium measurements using maximum-likelihood methods Lessons learned from comparing molecular dynamics engines on the SAMPL5 dataset Image Processing in Cryo-Electron Microscopy of Single Particles: The Power of Combining Methods Principal component analysis is limited to lowresolution analysis in cryoEM A glycan gate controls opening of the SARS-CoV-2 spike protein No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2 Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination SPHIRE-crYOLO is a fast and accurate fully automated particle picker for cryo-EM Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein Vulnerabilities in coronavirus glycan shields despite extensive glycosylation Developing a Fully Glycosylated Full-Length SARS-CoV-2 Spike Protein Model in a Viral Membrane Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM D614G mutation in the SARS-CoV-2 spike protein enhances viral fitness by desensitizing it to temperature-dependent denaturation Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant Structural impact on SARS-CoV-2 spike protein by D614G substitution Real-time CTF determination and correction ProDy 2.0: Increased Scale and Scope after 10 Years of Protein Dynamics Modelling with Python MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy CryoDRGN: reconstruction of heterogeneous cryo-EM structures using neural networks We want to particularly acknowledge the patients and the Consorcio Hospital General de Valencia Biobank integrated in the Valencian Biobanking Network for their collaboration in providing the convalescent serum samples. We acknowledge access to the cryoEM CNB-CSIC facility in the context of the CRIOMECORR project (ESFRI-2019-01-CSIC-16), and in particular the help of its staff. CPU time was partially provided by the PL-Grid Infrastructure. These authors contributed equally: Tiziana Ginex (TG), Clara Marco-Marín (CMM), Miłosz Wieczór (MW), Carlos P. Mata (CPM), James Krieger (JK).TG coordinated and performed the MD simulations, analysed the results and contributed to write the manuscript. CMM helped to make the samples for in vitro functional assays and preparation of cryo-EM grids, to build the structural models, to analyse the data, to supervise the work and to write the manuscript. MW performed the MD simulations and the free energy calculations, analysed the results and wrote the manuscript. CPM performed the cryo-EM image processing, analysed the results and contributed to write the manuscript. JK performed the PCA of experimental S:D614G structures, and helped with analysing the MD simulations and writing the manuscript. MLLR prepared the cryo-EM grids, helped to collect the cryo-EM data, to build the structural models, to analyse the data, and to write the manuscript. CFG produced the pseudotype virus, performed the pseudotype neutralization assays, and analyzed the results. PRR prepared the global sequence set, performed sequence and phylogenetic analysis, and wrote the manuscript. RM collected the cryo-EM data and was involved in the cryo-EM image processing. COSS and MM were involved in the cryo-EM image processing. NG helped to make the samples for in vitro functional assays and formation of cryo-EM grids. AFN performed the thermal shift assay. SZC, RGR and CSF performed the biolayer interferometry assays. JB, VR, and AM supervised the work and helped to write the manuscript. The IBV-Covid19-Pipeline produced the ACE2 protein used in biolayer interferometry assays. RG supervised the neutralization assay and helped to write the manuscript. IC supervised the work and helped to write the manuscript. CG supervised the work and helped in the preparation of the manuscript. MC supervised sequences and phylogenetic analysis and wrote the manuscript. MO supervised the work and helped to write the manuscript. JLL supervised the Authors do not have competing interests. Supplementary Figures 1-13 , Movie 1 and Supplementary Tables 1-5.